{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T20:00:39Z","timestamp":1785528039546,"version":"3.56.0"},"reference-count":52,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,12,3]],"date-time":"2020-12-03T00:00:00Z","timestamp":1606953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>We present an unusual case of 68-year-old male, who presented with acute abdomen, ulcerative jejunitis with perforation, and 2 months later with perforation of the sigmoid colon. We will also discuss difficulties in the delay in diagnosis of refractory celiac disease (RCD), specifically the atypical presentation, multiple surgeries, the consecutive failure of distinct therapeutic options, and multiple complications that occurred within the 3 months since first presentation.<\/jats:p>","DOI":"10.3389\/fmed.2020.564875","type":"journal-article","created":{"date-parts":[[2020,12,4]],"date-time":"2020-12-04T06:32:22Z","timestamp":1607063542000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Refractory Celiac Disease Type II: A Case Report and Literature Review"],"prefix":"10.3389","volume":"7","author":[{"given":"Richa","family":"Chibbar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan","family":"Nostedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Mihalicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Deschenes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross","family":"McLean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Levinus A.","family":"Dieleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,12,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12916-019-1380-z","article-title":"Celiac disease: a comprehensive current review","volume":"17","author":"Caio","year":"2019","journal-title":"BMC Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"237","DOI":"10.5009\/gnl.2009.3.4.237","article-title":"Adult celiac disease and its malignant complications","volume":"3","author":"Freeman","year":"2009","journal-title":"Gut Liver."},{"key":"B3","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.gtc.2018.09.010","article-title":"Refractory celiac disease","volume":"48","author":"Malamut","year":"2019","journal-title":"Gastroenterol Clin N Am."},{"key":"B4","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1586\/17474124.2016.1124759","article-title":"Refractory celiac disease","volume":"10","author":"Rishi","year":"2016","journal-title":"Expert Rev Gastroenterol Hepatol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1053\/j.gastro.2008.09.069","article-title":"Presentation and long-term follow-up of refractory celiac disease: comparison of type I with type II","volume":"136","author":"Malamut","year":"2009","journal-title":"Gastroenterology."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1136\/gut.2006.114512","article-title":"Survival in refractory celiac disease and enteropathy-associated T-cell lymphoma: retrospective evaluation of single-center experience","volume":"56","author":"Al-Toma","year":"2007","journal-title":"Gut."},{"key":"B7","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1053\/j.gastro.2008.10.013","article-title":"Clinical staging and survival in refractory celiac disease: a single center experience","volume":"136","author":"Rubio-Tapia","year":"2009","journal-title":"Gastroenterology."},{"key":"B8","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/apt.13867","article-title":"Dynamics of occurrence of refractory coeliac disease and associated complications over 25 years","volume":"45","author":"Eigner","year":"2017","journal-title":"Alimen Pharmacol Ther."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1016\/j.cgh.2007.08.013","article-title":"HLA DQ gene dosage and risk and severity of celiac disease","volume":"5","author":"Murray","year":"2007","journal-title":"Clin Gastroenterol Hepatol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.cgh.2005.12.011","article-title":"Human leukocyte antigen-DQ2 homozygosity and the development of refractory celiac disease and enteropathy-associated T-cell lymphoma","volume":"4","author":"Al-Toma","year":"2006","journal-title":"Clin Gastroenterol Hepatol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/S0016-5085(71)80012-4","article-title":"Chronic ulcerative jejunitis: report of a case and discussion of classification","volume":"60","author":"Moritz","year":"1971","journal-title":"Gastroenterology."},{"key":"B12","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1136\/gut.24.6.565","article-title":"Small intestinal ulceration: diagnostic difficulties in relation to coeliac disease","volume":"24","author":"Robertson","year":"1983","journal-title":"Gut."},{"key":"B13","article-title":"Lymphoproliferative disorders of the gastrointestinal tract","volume-title":"Gastrointestinal Pathology and its Clinical Implications","author":"Jain","year":"2014"},{"key":"B14","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1136\/jcp.51.3.207","article-title":"Lymphocytic gastritis and coeliac disease: evidence of a positive association","volume":"51","author":"Feeley","year":"1998","journal-title":"J Clin Pathol."},{"key":"B15","first-page":"57","article-title":"Update on the management of refractory coeliac disease","volume":"16","author":"Al-Toma","year":"2007","journal-title":"J Gastrointestin Liver Dis."},{"key":"B16","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1136\/gut.52.2.205","article-title":"Refractory coeliac sprue is a diffuse gastrointestinal disease","volume":"52","author":"Verkarre","year":"2003","journal-title":"Gut."},{"key":"B17","doi-asserted-by":"publisher","first-page":"969","DOI":"10.12688\/f1000research.18701.1","article-title":"Recent advances in celiac disease and refractory celiac disease","volume":"8","author":"Malamut","year":"2019","journal-title":"F1000 Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00261-016-1032-0","article-title":"Cross-sectional imaging in refractory celiac disease","volume":"42","author":"Al-Bawardy","year":"2017","journal-title":"Abdom Radiol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.gie.2017.04.006","article-title":"Use of enteroscopy for the detection of malignant and premalignant lesions of small bowel in complicated celiac disease: a meta-analysis","volume":"86","author":"Elli","year":"2017","journal-title":"Gastrointest Endosc."},{"key":"B20","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0140-6736(00)02481-8","article-title":"Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma. French Coeliac Disease Study Group","volume":"356","author":"Cellier","year":"2000","journal-title":"Lancet."},{"key":"B21","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1038\/ajg.2017.71","article-title":"Open-capsule budesonide for refractory celiac disease","volume":"112","author":"Mukewar","year":"2017","journal-title":"Am J Gastroenterol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1046\/j.1365-2036.2003.01687.x","article-title":"Azathioprine and prednisone combination therapy in refractory celiac disease","volume":"18","author":"Goerres","year":"2003","journal-title":"Aliment Pharmacol Ther."},{"key":"B23","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1159\/000092639","article-title":"Therapy with budesonide in patients with refractory sprue","volume":"73","author":"Daum","year":"2006","journal-title":"Digestion."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1111\/j.1572-0241.2007.01380.x","article-title":"Budesonide in the treatment of refractory celiac disease","volume":"102","author":"Brar","year":"2007","journal-title":"Am J Gastroentereol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1111\/j.1572-0241.2002.06029.x","article-title":"Azathioprine in refractory sprue: results from a prospective, open-label study","volume":"97","author":"Maurino","year":"2002","journal-title":"Am J Gastroentereol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1080\/17512433.2016.1200463","article-title":"Current and novel therapeutic strategies in celiac disease","volume":"9","author":"Kurada","year":"2016","journal-title":"Exp Rev Clin Pharmacol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/nrgastro.2015.155","article-title":"Mechanisms and management of refractory coeliac disease","volume":"12","author":"van Gils","year":"2015","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.7326\/0003-4819-119-10-199311150-00008","article-title":"Successful treatment of refractory sprue with cyclosporine","volume":"119","author":"Longstretch","year":"1993","journal-title":"Ann Intern Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1046\/j.1365-2036.2000.00718.x","article-title":"Cyclosporin in the treatment of adults with refractory coeliac disease \u2013 an open pilot study","volume":"14","author":"Wahab","year":"2000","journal-title":"Aliment Pharmacol Ther."},{"key":"B30","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.humimm.2009.09.351","article-title":"Serum cytokine elevations in celiac disease: association with disease presentation","volume":"71","author":"Manavalan","year":"2010","journal-title":"Hum Immunol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1097\/00042737-200110000-00010","article-title":"A pilot study of recombinant human interleukin-10 in adults with refractory coeliac disease","volume":"13","author":"Mulder","year":"2001","journal-title":"Eur J Gastroenterol Hepatol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1053\/gast.2002.31874","article-title":"Successful Infliximab treatment for steroid-refractory celiac disease: a case report","volume":"122","author":"Gillett","year":"2002","journal-title":"Gastroenterology."},{"key":"B33","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1097\/00042737-200506000-00002","article-title":"Infliximab in refractory coeliac disease","volume":"17","author":"Chaudhary","year":"2005","journal-title":"Eur J Gastroenterol Hepatol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1097\/00042737-200506000-00012","article-title":"Refractory coeliac disease: remission with infliximab and immunomodulators","volume":"17","author":"Turner","year":"2005","journal-title":"Eur J Gastroenterol Hepatol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2514","DOI":"10.1056\/NEJMc053129","article-title":"Alemtuzumab for refractory celiac disease in a patient at risk for enteropathy-associated T-cell lymphoma","volume":"354","author":"Vivas","year":"2006","journal-title":"N Engl J Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"506","DOI":"10.3748\/wjg.v17.i4.506","article-title":"Evaluation of Cladribine treatment in refractory celiac disease type II","volume":"17","author":"Tack","year":"2011","journal-title":"World J Gastroenterol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1016\/j.cgh.2006.07.007","article-title":"Cladribine therapy in refractory celiac disease with aberrant T cells","volume":"4","author":"Al-Toma","year":"2006","journal-title":"Clin Gastroenterol Hepatol."},{"key":"B38","first-page":"1","article-title":"Epidemiologic and therapeutic aspects of refractory celiac disease \u2013 a systematic review","volume":"63","author":"Rowinski","year":"2016","journal-title":"Dan Med J."},{"key":"B39","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1177\/2050640616646529","article-title":"Lymphoma development and survival in refractory coeliac disease type II: histological response as a prognostic factor","volume":"5","author":"Nijeboer","year":"2017","journal-title":"United Eur Gastroenterol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1007\/s10875-012-9849-y","article-title":"Tofacitinib, a janus kinase inhibitor demonstrates efficacy in an IL-15 transgenic mouse model that recapitulates pathologic manifestations of celiac disease","volume":"33","author":"Yokoyama","year":"2013","journal-title":"J Clin Immunol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.3389\/fimmu.2018.01603","article-title":"Beneficial effects of human Anti-interleukin\u221215 antibody in gluten sensitive rhesus macaques with celiac disease","volume":"9","author":"Sestak","year":"2018","journal-title":"Front Immunol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3389\/fped.2019.00193","article-title":"Evolving therapy for celiac disease","volume":"7","author":"Yoosuf","year":"2019","journal-title":"Front Pediatri."},{"key":"B43","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/S2468-1253(19)30265-1","article-title":"RCD II study group investigators. Safety and efficacy of AMG714 in patients with type 2 refractory coeliac disease: a phase 2a, randomized, double blind, placebo-controlled, parallel group study","volume":"4","author":"Cellier","year":"2019","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"385","DOI":"10.15403\/jgld.2014.1121.253.cel","article-title":"Serendipity in refractory celiac disease: full recovery of duodenal villi and clinical symptoms after fecal microbiota transfer","volume":"25","author":"van Beurden","year":"2016","journal-title":"J Gastrointestin Liv Dis."},{"key":"B45","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1182\/blood-2006-08-042820","article-title":"Autologous hematopoietic stem cell transplantation in refractory celiac disease with aberrant T cells","volume":"109","author":"Al-Toma","year":"2007","journal-title":"Blood."},{"key":"B46","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/bmt.2010.199","article-title":"Auto-SCT in refractory celiac disease type II patients unresponsive to cladribine therapy","volume":"46","author":"Tack","year":"2011","journal-title":"Bone Marrow Transplant."},{"key":"B47","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.mayocp.2016.03.001","article-title":"A refractory celiac patient successfully treated with mesenchymal stem cell infusions","volume":"91","author":"Ciccocioppo","year":"2016","journal-title":"Mayo Clin Proc."},{"key":"B48","doi-asserted-by":"publisher","first-page":"bcr2015209363","DOI":"10.1136\/bcr-2015-209363","article-title":"A 37 year-old woman with refractory coeliac disease type II treated by stem cell transplantation","volume":"2015","author":"Maheswari","year":"2015","journal-title":"BMC Case Rep."},{"key":"B49","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.dld.2007.03.009","article-title":"Disappointing outcome of autologous stem cell transplantation for enteropathy-associated T-cell lymphoma","volume":"39","author":"Al-Toma","year":"2007","journal-title":"Dig Liver Dis."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1002\/stem.2367","article-title":"Concise review: cellular therapies: the potential to regenerate and restore tolerance in immune mediated intestinal diseases","volume":"34","author":"Ciccocioppo","year":"2016","journal-title":"Stem Cells."},{"key":"B51","doi-asserted-by":"publisher","first-page":"12403","DOI":"10.3748\/wjg.v21.i43.12403","article-title":"Surgery in (pre)malignant celiac disease","volume":"21","author":"Van de Water","year":"2015","journal-title":"World J Gastroenterol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1111\/apt.14490","article-title":"Coeliac disease in later life must not be missed","volume":"47","author":"Collin","year":"2018","journal-title":"Aliment Pharmacol Ther."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2020.564875\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,4]],"date-time":"2020-12-04T06:32:25Z","timestamp":1607063545000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2020.564875\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,3]]},"references-count":52,"alternative-id":["10.3389\/fmed.2020.564875"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2020.564875","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,3]]},"article-number":"564875"}}